nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—Leukaemia—Teniposide—lymphatic system cancer	0.0722	0.0722	CcSEcCtD
Etidronic acid—Leukaemia—Vincristine—lymphatic system cancer	0.0388	0.0388	CcSEcCtD
Etidronic acid—Osteoporosis—Fludarabine—lymphatic system cancer	0.0305	0.0305	CcSEcCtD
Etidronic acid—Leukaemia—Methotrexate—lymphatic system cancer	0.0188	0.0188	CcSEcCtD
Etidronic acid—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Etidronic acid—Oesophagitis—Fludarabine—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Etidronic acid—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Etidronic acid—Osteonecrosis—Methotrexate—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Etidronic acid—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Etidronic acid—Alopecia—Mechlorethamine—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Etidronic acid—Pancytopenia—Teniposide—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Etidronic acid—Bone pain—Vincristine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Etidronic acid—Bone pain—Mitoxantrone—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Etidronic acid—Leukopenia—Mechlorethamine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Etidronic acid—Pancytopenia—Fludarabine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00948	0.00948	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00937	0.00937	CcSEcCtD
Etidronic acid—Arthritis—Bleomycin—lymphatic system cancer	0.00936	0.00936	CcSEcCtD
Etidronic acid—Infection—Mechlorethamine—lymphatic system cancer	0.00935	0.00935	CcSEcCtD
Etidronic acid—Osteoporosis—Methotrexate—lymphatic system cancer	0.00904	0.00904	CcSEcCtD
Etidronic acid—Multiple fractures—Methotrexate—lymphatic system cancer	0.00872	0.00872	CcSEcCtD
Etidronic acid—Fracture—Methotrexate—lymphatic system cancer	0.00872	0.00872	CcSEcCtD
Etidronic acid—Alopecia—Teniposide—lymphatic system cancer	0.00863	0.00863	CcSEcCtD
Etidronic acid—Amnesia—Carmustine—lymphatic system cancer	0.00845	0.00845	CcSEcCtD
Etidronic acid—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00812	0.00812	CcSEcCtD
Etidronic acid—Anaemia—Teniposide—lymphatic system cancer	0.00786	0.00786	CcSEcCtD
Etidronic acid—Leukopenia—Teniposide—lymphatic system cancer	0.00761	0.00761	CcSEcCtD
Etidronic acid—Alopecia—Fludarabine—lymphatic system cancer	0.00759	0.00759	CcSEcCtD
Etidronic acid—Pancytopenia—Bleomycin—lymphatic system cancer	0.00747	0.00747	CcSEcCtD
Etidronic acid—Confusional state—Teniposide—lymphatic system cancer	0.007	0.007	CcSEcCtD
Etidronic acid—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00693	0.00693	CcSEcCtD
Etidronic acid—Anaemia—Fludarabine—lymphatic system cancer	0.00691	0.00691	CcSEcCtD
Etidronic acid—Infection—Teniposide—lymphatic system cancer	0.00689	0.00689	CcSEcCtD
Etidronic acid—Leukopenia—Fludarabine—lymphatic system cancer	0.00669	0.00669	CcSEcCtD
Etidronic acid—Pruritus—Mechlorethamine—lymphatic system cancer	0.00666	0.00666	CcSEcCtD
Etidronic acid—Pancytopenia—Carmustine—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Etidronic acid—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00644	0.00644	CcSEcCtD
Etidronic acid—Arthralgia—Fludarabine—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Etidronic acid—Discomfort—Fludarabine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Etidronic acid—Pancytopenia—Vincristine—lymphatic system cancer	0.00622	0.00622	CcSEcCtD
Etidronic acid—Confusional state—Fludarabine—lymphatic system cancer	0.00615	0.00615	CcSEcCtD
Etidronic acid—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Etidronic acid—Infection—Fludarabine—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.006	0.006	CcSEcCtD
Etidronic acid—Vomiting—Mechlorethamine—lymphatic system cancer	0.00598	0.00598	CcSEcCtD
Etidronic acid—Rash—Mechlorethamine—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Etidronic acid—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Etidronic acid—Feeling abnormal—Teniposide—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Etidronic acid—Nausea—Mechlorethamine—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Etidronic acid—Alopecia—Bleomycin—lymphatic system cancer	0.00556	0.00556	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00556	0.00556	CcSEcCtD
Etidronic acid—Urticaria—Teniposide—lymphatic system cancer	0.00551	0.00551	CcSEcCtD
Etidronic acid—Glossitis—Methotrexate—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Etidronic acid—Abdominal pain—Teniposide—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Etidronic acid—Erythema—Bleomycin—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Etidronic acid—Paraesthesia—Fludarabine—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Etidronic acid—Hallucination—Carmustine—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Etidronic acid—Dyspepsia—Fludarabine—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Etidronic acid—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Etidronic acid—Hallucination—Vincristine—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Etidronic acid—Constipation—Fludarabine—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Etidronic acid—Hypersensitivity—Teniposide—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Etidronic acid—Anaemia—Bleomycin—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Etidronic acid—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Etidronic acid—Pruritus—Teniposide—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Etidronic acid—Leukopenia—Bleomycin—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Etidronic acid—Alopecia—Carmustine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Etidronic acid—Erythema—Carmustine—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Etidronic acid—Diarrhoea—Teniposide—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Etidronic acid—Alopecia—Vincristine—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Etidronic acid—Discomfort—Bleomycin—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Etidronic acid—Alopecia—Mitoxantrone—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Etidronic acid—Confusional state—Bleomycin—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Etidronic acid—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Etidronic acid—Erythema—Mitoxantrone—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Etidronic acid—Infection—Bleomycin—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Etidronic acid—Anaemia—Carmustine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Etidronic acid—Vomiting—Teniposide—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Etidronic acid—Rash—Teniposide—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Etidronic acid—Dermatitis—Teniposide—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Etidronic acid—Headache—Teniposide—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Etidronic acid—Pruritus—Fludarabine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Etidronic acid—Leukopenia—Carmustine—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Etidronic acid—Anaemia—Vincristine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Etidronic acid—Diarrhoea—Fludarabine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Etidronic acid—Nausea—Teniposide—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Etidronic acid—Anaemia—Mitoxantrone—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Etidronic acid—Leukopenia—Vincristine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Etidronic acid—Paraesthesia—Bleomycin—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Etidronic acid—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Etidronic acid—Confusional state—Carmustine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Etidronic acid—Infection—Carmustine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Etidronic acid—Vomiting—Fludarabine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Etidronic acid—Rash—Fludarabine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Etidronic acid—Dermatitis—Fludarabine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Etidronic acid—Headache—Fludarabine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Etidronic acid—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Etidronic acid—Discomfort—Mitoxantrone—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Etidronic acid—Infection—Vincristine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Etidronic acid—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Etidronic acid—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Etidronic acid—Confusional state—Mitoxantrone—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Etidronic acid—Nausea—Fludarabine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Etidronic acid—Infection—Mitoxantrone—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Etidronic acid—Urticaria—Bleomycin—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Etidronic acid—Paraesthesia—Carmustine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Etidronic acid—Paraesthesia—Vincristine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Etidronic acid—Constipation—Carmustine—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Etidronic acid—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Etidronic acid—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Etidronic acid—Feeling abnormal—Carmustine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Etidronic acid—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Etidronic acid—Constipation—Vincristine—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Etidronic acid—Asthma—Methotrexate—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Etidronic acid—Pruritus—Bleomycin—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Etidronic acid—Constipation—Mitoxantrone—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Etidronic acid—Abdominal pain—Carmustine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Etidronic acid—Pancytopenia—Methotrexate—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Etidronic acid—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Etidronic acid—Abdominal pain—Vincristine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Etidronic acid—Urticaria—Mitoxantrone—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Etidronic acid—Hypersensitivity—Carmustine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Etidronic acid—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Etidronic acid—Vomiting—Bleomycin—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Etidronic acid—Rash—Bleomycin—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Etidronic acid—Dermatitis—Bleomycin—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Etidronic acid—Hypersensitivity—Vincristine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Etidronic acid—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Etidronic acid—Diarrhoea—Carmustine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Etidronic acid—Nausea—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Etidronic acid—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Etidronic acid—Diarrhoea—Vincristine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Etidronic acid—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Etidronic acid—Vomiting—Carmustine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Etidronic acid—Rash—Carmustine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Etidronic acid—Dermatitis—Carmustine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Etidronic acid—Headache—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Etidronic acid—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Etidronic acid—Vomiting—Vincristine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Etidronic acid—Rash—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Etidronic acid—Dermatitis—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Etidronic acid—Headache—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Etidronic acid—Nausea—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Etidronic acid—Vomiting—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Etidronic acid—Rash—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Etidronic acid—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Etidronic acid—Headache—Mitoxantrone—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Etidronic acid—Alopecia—Methotrexate—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Etidronic acid—Erythema—Methotrexate—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Etidronic acid—Nausea—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Etidronic acid—Nausea—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Etidronic acid—Anaemia—Methotrexate—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Etidronic acid—Leukopenia—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Etidronic acid—Arthralgia—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Etidronic acid—Discomfort—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Etidronic acid—Confusional state—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Etidronic acid—Infection—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Etidronic acid—Paraesthesia—Methotrexate—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Etidronic acid—Dyspepsia—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Etidronic acid—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Etidronic acid—Urticaria—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Etidronic acid—Abdominal pain—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Etidronic acid—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Etidronic acid—Pruritus—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Etidronic acid—Diarrhoea—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Etidronic acid—Vomiting—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Etidronic acid—Rash—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Etidronic acid—Dermatitis—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Etidronic acid—Headache—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Etidronic acid—Nausea—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
